Role of Oral Lesions in Diagnosing Generalised Recessive Dystrophic Epidermolysis Bullosa- A Rare Case Report
Epidermolysis bullosa (EB) is a heterogeneous group of genetically determined, vesiculo-bullous disorders characterized by blister formation in response to mechanical trauma. Three major subgroups, simplex, junctional, and dystrophic EB, contain more than 20 genetically and clinically distinct subtypes. In the present case, we described a patient diagnosed with a milder variant of generalised recessive dystrophic epidermolysis bullosa with specific oral and cutaneous lesions, which was previously named as non-Hallopeau-Siemans subtype.
Serrano-Martínez MC, Bagán JV, Silvestre FJ, et al. Oral lesions in recessive Dystrophic Epidermolysis Bullosa. Oral Dis 2003;9:264-268.
Leena Bruckner-Tuderman. Dystrophic Epidermolysis Bullosa: Pathogenesis and clinical features. Dermatol Clin 2010;28:107-114.
Fine JD, Johnson LB, Suchindran C, et al. Eye involvement in inherited epidermolysis bullosa (EB): Experience of the National EB Registry. Am J Ophthalmol 2004;138:254-262.
Fine JD, Johnson LB, Weiner M, et al. Gastrointestinal complications of inherited epidermolysis bullosa: Cumulative experience of the National EB Registry. J Pediatr Gastroenterol Nutr 2008;46:147-158.
Fine JD, Johnson LB, Weiner M, et al. Pseudosyndactyly and musculoskeletal deformities in inherited epidermolysis bullosa (EB): Experience of the National EB Registry, 1986-2002. J Hand Surg (British and European Volume) 2005;30:14-22.
Alper JC, Baden HP, Goldsmith LA. Kindler's syndrome. Arch Dermatol 1978;114:457.
Fine JD, Eady RAJ, Bauer JA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-950.
Shimizu H, Sato M, Ban M, et al. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa. Arch Dermatol 1997;133:1111-1117.
Hashimoto I, Schnyder UW, Anton-Lamprecht I, et al. Ultrastructural studies in epider¬molysis bullosa hereditaria. III. Recessive dystrophic types with dermolytic blistering (Hallopeau-Siemens types and inverse type). Arch Dermatol Res 1976;256:137-150.
Kahofer P, Bruckner-Tuderman L, Metze D, et al. Dystrophic epidermolysis bullosa inversa with COL7A1 mutations and absence of GDA-J/F3 protein. Pediatr Dermatol 2003;20:243-248.
Wojnarowska FT, Eady RA, Wells RS. Dystrophic epidermolysis bullosa presenting with congenital localized absence of skin: Report of four cases. Br J Dermatol 1983;108:477-483.
Sweet SP, Ballsdon AE, Harris JC, et al. Impaired secretory immunity in dystrophic epidermolysis bullosa. Oral Microbiol Immunol 1999;14:316-320.
Fine JD, Johnson LB, Weiner M, et al. Inherited epidermolysis bullosa (EB) and the risk of death from renal disease: Experience of the National EB Registry. Am J Kidney Dis 2004;44:651-660.
Wright JT, Johnson LB, Fine JD. Developmental defects of enamel in humans with hereditary epidermolysis bullosa. Arch Oral Biol 1993;38:945-955.
Fine JD, Hall M, Weiner M, et al. The risk of cardiomyopathy in inherited epidermolysis bullosa. Br J Dermatol 2008;159:677-682.
Fine JD, Johnson LB, Weiner M, et al. Inherited epidermolysis bullosa (EB) and the risk of life-threatening skin-derived cancers: Experience of the National EB Registry,1986-2006. J Am Acad Dermatol 2009;60:203-211.
Fine JD, Tamura T, Johnson L. Blood vitamin and trace metal levels in epidermolysis bullosa. Arch Dermatol 1989;125:374-379.
Briggaman RA. Recessive dystrophic epidermolysis bullosa: A clinical overview. In: Epidermolysis Bullosa. Basic and Clinical Aspects. Lin AN, Carter DM (eds.). Springler-Verlag, New York, 1992: 135-151.
Wright JT, Fine JD, Johnson LB, et al. Oral in¬volvement of recessive dystrophic epidermolysis bullosa inversa. Am J Med Genet 1993;47:1184-1188.
Gache Y, Pin D, Gagnoux-Palacios L, et al. Correction of dog dystrophic epider¬molysis bullosa by transplantation of genetically modified epidermal autografts. J Invest Dermatol 2011;12:312-315.
Copyright (c) 2015 Acta Medica Scientia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
A) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
B) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
C) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).